Clinical Trial Update: R-CHOP Alone vs. R-CHOP Plus Radiotherapy for Localized CD20+ DLBCL [Phase 3]

View source ↗

Summary

Phase 3 trial comparing R-CHOP alone versus R-CHOP with radiotherapy for localized CD20+ Diffuse Large B-Cell Lymphoma was withdrawn (sponsor: Asan Medical Cent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Asan Medical Center | Conditions: Diffuse Large B-cell Lymphoma | Phase 3 | Status: WITHDRAWN